Literature DB >> 19268002

Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.

C Ged1, F Moreau-Gaudry, E Richard, E Robert-Richard, H de Verneuil.   

Abstract

High quality genotype/phenotype analysis is a difficult issue in rare genetic diseases such as congenital erythropoietic porphyria (CEP) or Günther's disease, a heme biosynthesis defect due to uroporphyrinogen III synthase deficiency. The historical background and the main phenotypic features of the disease are depicted together with an update of published mutants and genotype/phenotype correlations. General rules concerning the prediction of disease severity are drawn as a guide for patient management and therapeutic choices. The phenotypic heterogeneity of the disease is presented in relation with a likely influence of modifying factors, either genetic or acquired.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268002

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  15 in total

1.  The porphyrias: pathophysiology.

Authors:  Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

Review 2.  [Congenital erythropoietic porphyria : An update].

Authors:  C Wenner; N J Neumann; J Frank
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

3.  Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.

Authors:  Sarah Millot; Constance Delaby; Boualem Moulouel; Thibaud Lefebvre; Nathalie Pilard; Nicolas Ducrot; Cécile Ged; Philippe Lettéron; Lucia de Franceschi; Jean Charles Deybach; Carole Beaumont; Laurent Gouya; Hubert De Verneuil; Saïd Lyoumi; Hervé Puy; Zoubida Karim
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

Review 4.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

5.  Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.

Authors:  Daniel N Egan; Zhantao Yang; John Phillips; Janis L Abkowitz
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

6.  Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R.

Authors:  Arola Fortian; Esperanza González; David Castaño; Juan M Falcon-Perez; Oscar Millet
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

7.  Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes.

Authors:  David F Bishop; Sonia Clavero; Narla Mohandas; Robert J Desnick
Journal:  Mol Med       Date:  2011-02-25       Impact factor: 6.354

Review 8.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

9.  Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.

Authors:  Jean-Marc Blouin; Yann Duchartre; Pierre Costet; Magalie Lalanne; Cécile Ged; Ana Lain; Oscar Millet; Hubert de Verneuil; Emmanuel Richard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

10.  Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.

Authors:  Aurélie Bedel; Miguel Taillepierre; Véronique Guyonnet-Duperat; Eric Lippert; Pierre Dubus; Sandrine Dabernat; Thibaud Mautuit; Bruno Cardinaud; Catherine Pain; Benoît Rousseau; Magalie Lalanne; Cécile Ged; Yann Duchartre; Emmanuel Richard; Hubert de Verneuil; François Moreau-Gaudry
Journal:  Am J Hum Genet       Date:  2012-07-13       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.